Aetion is partnering with the Institute for Clinical and Economic Review (ICER) to incorporate real-world evidence (RWE) into drug value assessments. Aetion's data platform will be used by ICER to analyze the effectiveness and value of new drugs, particularly in situations where data on comparator treatments or the natural course of a disease is needed.
Read More
Read More